Facial Nerve Paralysis

3

Review clinical trials related to Facial Nerve Paralysis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Treatment for "Asymmetric Crying Facies"

This study focuses on children with hemifacial microsomia (HFM), a common congenital craniofacial deformity caused by abnormal development of the first and second branchial arches. Up to 45% of children with HFM have facial nerve dysplasia, most frequently involving the mandibular marginal branch. These children present with asymmetric lower-lip movement called "crooked-mouth smile" during smiling, speaking or crying. Unlike asymmetric crying syndrome, this condition does not resolve spontaneously and may gradually get worse. "Crooked-mouth smile" results from muscle weakness of the lower lip on the affected side, leading to dynamic perioral muscle imbalance. Static treatment includes botulinum toxin injection, muscle resection, nerve cutting and fascia suspension; dynamic treatment includes muscle transfer procedures. Early intervention is important for children's psychological well-being. Botulinum toxin injection is minimally invasive, safe and reversible, and is regarded as a preferred initial therapy. However, prospective clinical evidence regarding its efficacy, safety and appropriate dosage in this pediatric population remains insufficient. This prospective study aims to explore the safety, effectiveness and optimal dose of botulinum toxin injection for treating "crooked-mouth smile" in children with HFM and mandibular marginal branch dysplasia.

Participants needed: 60
Trial details
Age: 5-18Biological sex: AllType: InterventionalSponsor: Xiaolei JinUpdated: Sep 28, 2026Locations: 1
Eligibility criteria

Children under 18 years old diagnosed with hemifacial microsomia (HFM) and lower... [+2]

Any disease affecting neuromuscular function, including but not limited to neuro... [+10]

Status: Not yet recruiting

Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patients With Bell's Palsy

This observational study aims to assess the concurrent validity of an artificial intelligence (AI)-based facial paralysis assessment system in patients with unilateral Bell's palsy. Currently, clinical assessment relies on subjective scales like the Sunnybrook Facial Grading System, which can vary between different observers. This study will compare AI-generated composite asymmetry scores-derived from real-time computer vision analysis of facial landmarks-with scores from the Sunnybrook system. The goal is to determine if AI can provide a valid, objective method for monitoring facial nerve recovery.

Participants needed: 63
Trial details
Age: 25-40Biological sex: AllType: ObservationalSponsor: Cairo UniversityUpdated: May 7, 2026Locations: 1
Eligibility criteria

Patients with unilateral Bell's palsy. [+3]

Bilateral facial paralysis or recurrent Bell's palsy. [+3]

Status: Not yet recruiting

Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

The purpose of this study is to evaluate the efficacy and safety of steroids treatment compared with placebo in preserving facial nerve function after craniotomy in patients with vestibular schwannoma who have not received preoperative treatment and have good intraoperative facial nerve function.

Participants needed: 364
Trial details
Phase: Phase 3Age: 18-60Biological sex: AllType: InterventionalSponsor: Beijing Tiantan HospitalUpdated: Aug 12, 2025Locations: 1
Eligibility criteria

Age between 18 and 60 years [+4]

Contraindications for craniotomy [+6]